By Dani Kass ( November 5, 2021, 8:06 PM EDT) -- The Federal Circuit on Friday shot down Celgene's attempt to bring a patent infringement suit against West Virginia-based Mylan in New Jersey, claiming the presence of a few remote employees and the receipt of a notice tied to Mylan's generic drug application in the Garden State don't justify filing the suit there....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.